FDA Reclassification Announced

1 in 30 Women Will Need Revision Procedures Within 10 Years
September 21, 2015
Endo Closes It’s Doors
March 12, 2016

The FDA announces that it has reclassified transvaginal mesh as high-risk devices, requiring manufacturers to show that their products are safe and effective.

Leave a Reply

Your email address will not be published. Required fields are marked *